Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Current Leases (2019 - 2025)

Historic Current Leases for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $35.4 million.

  • CureVac's Current Leases fell 756.66% to $35.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.4 million, marking a year-over-year decrease of 756.66%. This contributed to the annual value of $36.0 million for FY2024, which is 56761.92% up from last year.
  • Latest data reveals that CureVac reported Current Leases of $35.4 million as of Q3 2025, which was down 756.66% from $35.3 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Current Leases registered a high of $41.0 million during Q1 2022, and its lowest value of $4.0 million during Q4 2021.
  • For the 5-year period, CureVac's Current Leases averaged around $31.3 million, with its median value being $36.3 million (2024).
  • Per our database at Business Quant, CureVac's Current Leases soared by 9336892.92% in 2021 and then plummeted by 1235.44% in 2025.
  • Quarter analysis of 5 years shows CureVac's Current Leases stood at $4.0 million in 2021, then rose by 28.03% to $5.1 million in 2022, then rose by 5.99% to $5.4 million in 2023, then surged by 567.62% to $36.0 million in 2024, then decreased by 1.47% to $35.4 million in 2025.
  • Its last three reported values are $35.4 million in Q3 2025, $35.3 million for Q2 2025, and $33.9 million during Q1 2025.